ResearcherCancer Research UK Manchester InstituteNo recent work listed

Sumitra Mohan

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0009-0008-1702-1429; OpenAlex author ID A5019947216.

Their work

Papers: 1 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 7

Papers, trials and grants by year

2019: 1 paper

Papers 1

Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer. First author DOI 10.1038/s41598-019-47489-7 ↗

Closest collaborators

The 7 strongest of 7 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Ángela Lamarca Lete · 1 shared paper, 2019
- Paper Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pan… DOI 10.1038/s41598-019-47489-7 ↗
Caroline Dive · 1 shared paper, 2019
- Paper Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pan… DOI 10.1038/s41598-019-47489-7 ↗
Antoine Hollebecque · 1 shared paper, 2019
- Paper Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pan… DOI 10.1038/s41598-019-47489-7 ↗
Richard A Hubner · 1 shared paper, 2019
- Paper Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pan… DOI 10.1038/s41598-019-47489-7 ↗
Juan W. Valle · 1 shared paper, 2019
- Paper Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pan… DOI 10.1038/s41598-019-47489-7 ↗
Mairead Geraldine McNamara · 1 shared paper, 2019
- Paper Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pan… DOI 10.1038/s41598-019-47489-7 ↗
Gerard Brady · 1 shared paper, 2019
- Paper Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pan… DOI 10.1038/s41598-019-47489-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.